Hub : Traits :

Primary Biliary Cirrhosis

113 significantly associated models · 37 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 67074053 68559650 1 1 3.3e-21 7.5e-28 2.0e-08 74 IL12RB2
2 1 196798989 198436809 1 1 1.9e-09 1.0e-11 1.1e-03 77 DENND1B
3 2 190521054 192091293 2 2 4.1e-10 2.3e-14 2.4e-04 77 INPP1 TMEM194B
4 3 159013779 160970437 4 2 1.2e-20 1.4e-23 3.0e-06 78 IFT80 TRIM59
5 4 258627 1694809 3 1 1.2e-07 2.7e-07 7.0e-02 88 SLC26A1
6 4 102852939 104627833 4 1 8.2e-10 8.2e-10 1.0e+00 100 SLC9B1
7 7 127878155 129284182 1 1 2.5e-18 5.1e-23 3.7e-12 51 IRF5
8 11 63316786 64820283 2 1 2.8e-09 1.7e-09 1.5e-01 94 CCDC88B
9 11 118365263 119765318 1 1 1.7e-08 1.1e-13 3.3e-07 53 CCDC153
10 12 5795712 6956462 1 1 3.8e-07 1.8e-09 6.6e-10 -5 LTBR
11 12 111154626 112582540 1 1 1.4e-07 3.2e-08 3.5e-03 72 SH2B3
12 15 78520204 79933757 1 1 2.4e-07 1.6e-07 1.0e+00 100 CTSH
13 16 10329905 12138068 4 2 6.6e-14 2.4e-14 1.0e+00 100 DEXI RMI2
14 17 36660684 39048774 9 6 9.3e-11 2.6e-11 1.0e+00 100 GSDMB ORMDL3 PNMT RPL19
15 19 10283932 11730690 1 1 2.0e-07 1.0e-10 5.0e-10 7 CARM1
16 22 39064209 40479448 1 1 6.7e-12 2.2e-11 4.4e-01 99 SYNGR1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Alzheimer’s Disease (in mother) 2.20 2 0 0.0 0.00 1.0e+00 CTSH SLC26A1
Alzheimer’s Disease (including proxy) 1.84 1 0 0.0 0.00 1.0e+00 SLC26A1
Crohns Disease (2017) 9.39 9 5 15.2 -0.72 1.3e-02 CCDC88B DENND1B GSDMB IL12RB2 LTBR ORMDL3 PNMT RMI2 SYNGR1
Irritable Bowel Disease (IBD) 11.83 10 6 18.2 -0.74 5.8e-03 CCDC88B DENND1B GSDMB IL12RB2 ORMDL3 PNMT RMI2 RPL19 SH2B3 SYNGR1
Ulcerative Colitis (UC) 8.87 8 4 12.1 -0.79 6.4e-03 GSDMB IL12RB2 IRF5 ORMDL3 PNMT RMI2 SLC9B1 SYNGR1
Reaction Time 2.25 2 1 3.0 0.00 1.0e+00 CARM1 SH2B3
Prostate Cancer 1.97 1 0 0.0 0.00 1.0e+00 TRIM59
Coronary Artery Disease (CAD) 1.54 1 0 0.0 0.00 1.0e+00 SH2B3
Crohns Disease (2012) 6.05 6 2 6.1 0.55 1.6e-01 CCDC88B GSDMB IL12RB2 ORMDL3 PNMT RMI2
Fasting Glucose 2.01 1 0 0.0 0.00 1.0e+00 SLC9B1
HDL Cholesterol 6.87 5 4 12.1 0.78 3.8e-02 GSDMB ORMDL3 PNMT RPL19 SYNGR1
LDL Cholesterol 4.83 3 1 3.0 0.00 1.0e+00 CARM1 SH2B3 TRIM59
Lupus 10.37 6 2 6.1 0.93 2.3e-03 DEXI GSDMB IL12RB2 IRF5 ORMDL3 TMEM194B
Rheumatoid Arthritis 9.03 8 1 3.0 0.99 6.1e-09 CCDC153 GSDMB IRF5 ORMDL3 PNMT RPL19 SH2B3 SYNGR1
Triglycerides 1.81 1 0 0.0 0.00 1.0e+00 INPP1
Ulcerative Colitis 7.51 5 3 9.1 0.74 5.8e-02 GSDMB IL12RB2 IRF5 ORMDL3 PNMT
Blood Eosinophil Count 11.39 9 5 15.2 0.35 3.6e-01 CARM1 CCDC88B DENND1B DEXI IRF5 LTBR RPL19 SH2B3 SLC9B1
Blood Platelet Count 2.59 13 6 18.2 0.22 4.5e-01 CCDC153 GSDMB INPP1 IRF5 LTBR ORMDL3 PNMT RMI2 RPL19 SH2B3 SYNGR1 TMEM194B TRIM59
Blood Red Count 2.49 9 3 9.1 -0.21 5.7e-01 GSDMB IFT80 ORMDL3 PNMT RPL19 SH2B3 SLC9B1 TMEM194B TRIM59
Blood White Count 25.44 10 5 15.2 -0.16 6.2e-01 CARM1 CCDC153 DEXI GSDMB ORMDL3 PNMT RPL19 SH2B3 SLC26A1 SLC9B1
Heel T-Score 1.02 6 1 3.0 -0.39 4.4e-01 CCDC153 CCDC88B IFT80 IL12RB2 IRF5 TRIM59
BMI 0.67 1 0 0.0 0.00 1.0e+00 DENND1B
Height 0.50 6 4 12.1 -0.10 8.5e-01 CARM1 INPP1 IRF5 RPL19 SH2B3 SYNGR1
Waist Hip Ratio (WHR) 0.92 1 1 3.0 0.00 1.0e+00 SLC26A1
Systolic Blood Pressure 3.39 5 4 12.1 0.38 5.3e-01 IFT80 IRF5 SH2B3 TMEM194B TRIM59
Smoking Status 1.46 1 0 0.0 0.00 1.0e+00 CCDC88B
Allergy or Eczema 6.58 8 5 15.2 -0.36 3.0e-01 CCDC153 DEXI GSDMB INPP1 ORMDL3 PNMT SH2B3 SLC9B1
Cardiovascular Disease 2.97 6 2 6.1 0.79 6.4e-02 CARM1 CCDC88B IFT80 SH2B3 SLC26A1 TRIM59
Hypothyroidism (self reported) 8.28 7 3 9.1 0.53 2.2e-01 CCDC88B IL12RB2 IRF5 SH2B3 SYNGR1 TMEM194B TRIM59
Respiratory disease 25.82 6 5 15.2 -0.18 6.7e-01 CCDC153 DEXI GSDMB ORMDL3 PNMT RPL19
Type 2 Diabetes (T2D) 1.87 1 0 0.0 0.00 1.0e+00 SH2B3
Lung FEV1/FVC ratio 1.47 4 1 3.0 0.06 9.1e-01 GSDMB LTBR ORMDL3 PNMT
Lung FVC 1.75 6 2 6.1 0.15 7.4e-01 CCDC153 DEXI GSDMB PNMT RPL19 SH2B3
Neuroticism 1.02 1 0 0.0 0.00 1.0e+00 DENND1B
Chronotype (morning person) 1.30 2 0 0.0 0.00 1.0e+00 IFT80 IL12RB2
Hair Pigment 0.22 3 2 6.1 0.00 1.0e+00 CARM1 SH2B3 SYNGR1
Tanning 0.33 2 1 3.0 0.00 1.0e+00 SH2B3 SYNGR1
Number of treatments/medications taken 3.39 3 1 3.0 0.00 1.0e+00 SH2B3 SLC9B1 TRIM59
Sensitivity / hurt feelings 0.96 1 0 0.0 0.00 1.0e+00 DENND1B
Other serious medical condition/disability diagnosed by doctor 2.11 2 0 0.0 0.00 1.0e+00 DEXI TMEM194B
Ever used hormone-replacement therapy (HRT) 1.99 2 0 0.0 0.00 1.0e+00 IFT80 TRIM59
Systolic blood pressure, automated reading 2.64 5 2 6.1 -0.45 4.5e-01 IFT80 SH2B3 SLC26A1 TMEM194B TRIM59
Impedance of leg (right) 0.86 3 0 0.0 0.00 1.0e+00 DENND1B IFT80 TRIM59
Leg fat-free mass (left) 0.76 3 0 0.0 0.00 1.0e+00 DENND1B IFT80 SH2B3
Trunk fat percentage 0.87 1 1 3.0 0.00 1.0e+00 SLC26A1
Maternal smoking around birth 0.99 1 0 0.0 0.00 1.0e+00 CCDC88B
Fed-up feelings 1.95 2 1 3.0 0.00 1.0e+00 CCDC88B SH2B3
Taking other prescription medications 5.20 5 1 3.0 -0.50 3.1e-01 DEXI GSDMB ORMDL3 PNMT SH2B3
Age when periods started (menarche) 1.28 2 0 0.0 0.00 1.0e+00 RPL19 SLC9B1
Heel bone mineral density (BMD) T-score, automated (left) 1.24 1 0 0.0 0.00 1.0e+00 CCDC153
High blood pressure 2.50 2 1 3.0 0.00 1.0e+00 SH2B3 TRIM59
Hayfever, allergic rhinitis or eczema 6.90 6 5 15.2 0.34 4.0e-01 CCDC153 DEXI GSDMB ORMDL3 PNMT SLC9B1
Multivitamins +/- minerals 1.67 1 0 0.0 0.00 1.0e+00 TMEM194B
Stomach or abdominal pain in last month 1.29 1 0 0.0 0.00 1.0e+00 CCDC153
Medication: Atenolol 1.89 1 1 3.0 0.00 1.0e+00 SH2B3
Medication: Levothyroxine sodium 6.39 3 1 3.0 0.00 1.0e+00 CCDC88B SH2B3 TMEM194B
Sitting height 0.54 2 0 0.0 0.00 1.0e+00 CTSH RMI2
Body mass index (BMI) 0.86 1 0 0.0 0.00 1.0e+00 DENND1B
Impedance of leg (left) 0.69 2 0 0.0 0.00 1.0e+00 DENND1B IFT80
Leg predicted mass (left) 0.77 3 0 0.0 0.00 1.0e+00 DENND1B IFT80 SH2B3
Trunk fat mass 0.86 2 1 3.0 0.00 1.0e+00 SLC26A1 SYNGR1
Waist circumference 1.05 1 1 3.0 0.00 1.0e+00 SLC26A1
Past tobacco smoking 2.01 3 0 0.0 0.00 1.0e+00 CCDC88B RPL19 SH2B3
Nervous feelings 1.22 1 0 0.0 0.00 1.0e+00 DENND1B
Forced vital capacity (FVC) 0.98 2 0 0.0 0.00 1.0e+00 CARM1 RPL19
Heel bone mineral density (BMD) T-score, automated (right) 1.36 1 0 0.0 0.00 1.0e+00 CCDC153
Qualifications: None of the above 1.78 1 0 0.0 0.00 1.0e+00 DENND1B
Mouth/teeth dental problems 1.69 1 0 0.0 0.00 1.0e+00 IRF5
Heart attack 1.76 1 0 0.0 0.00 1.0e+00 SH2B3
Allergy 12.85 7 5 15.2 -0.39 3.0e-01 CCDC153 DEXI GSDMB ORMDL3 PNMT RPL19 SLC9B1
Hayfever/allergic rhinitis (self-reported) 5.22 4 1 3.0 -0.85 3.2e-02 DEXI GSDMB ORMDL3 PNMT
Medication: Ramipril 1.67 1 0 0.0 0.00 1.0e+00 SH2B3
Medication: Simvastatin 2.33 1 1 3.0 0.00 1.0e+00 CARM1
Illnesses of siblings 1.90 1 0 0.0 0.00 1.0e+00 SH2B3
Weight 0.98 4 0 0.0 -0.59 4.1e-01 CCDC153 DENND1B SH2B3 SYNGR1
Impedance of arm (right) 1.42 5 0 0.0 -0.64 2.5e-01 GSDMB IFT80 ORMDL3 SH2B3 SLC9B1
Arm fat percentage (right) 0.68 1 1 3.0 0.00 1.0e+00 SLC26A1
Trunk fat-free mass 1.08 4 1 3.0 0.53 4.7e-01 IFT80 IL12RB2 SH2B3 SYNGR1
Hip circumference 1.18 2 0 0.0 0.00 1.0e+00 SH2B3 SYNGR1
Father's age at death 2.84 1 1 3.0 0.00 1.0e+00 SH2B3
Worrier / anxious feelings 1.12 1 0 0.0 0.00 1.0e+00 DENND1B
Number of live births 2.18 1 0 0.0 0.00 1.0e+00 SLC9B1
Forced expiratory volume in 1-second (FEV1) 1.29 2 0 0.0 0.00 1.0e+00 PNMT RPL19
Mouth/teeth dental problems: Dentures 3.43 3 0 0.0 0.00 1.0e+00 GSDMB ORMDL3 PNMT
Asthma 23.59 7 5 15.2 0.18 6.5e-01 CARM1 CCDC153 DEXI GSDMB ORMDL3 PNMT RPL19
Medication: Cholesterol lowering 1.44 1 0 0.0 0.00 1.0e+00 CARM1
Medication: Lansoprazole 1.23 1 0 0.0 0.00 1.0e+00 SH2B3
Illnesses of mother 1.45 1 0 0.0 0.00 1.0e+00 TRIM59
Forced expiratory volume in 1-second (FEV1), Best measure 1.43 3 0 0.0 0.00 1.0e+00 CARM1 PNMT RPL19
Pulse wave Arterial Stiffness index 1.61 1 0 0.0 0.00 1.0e+00 CCDC88B
Impedance of arm (left) 1.51 4 1 3.0 -0.91 9.3e-02 GSDMB ORMDL3 SH2B3 SLC9B1
Arm fat mass (right) 0.77 2 0 0.0 0.00 1.0e+00 DENND1B SLC26A1
Trunk predicted mass 1.09 4 1 3.0 0.52 4.8e-01 IFT80 IL12RB2 SH2B3 SYNGR1
Standing height 0.54 4 1 3.0 0.50 5.0e-01 CARM1 CTSH SH2B3 SYNGR1
Seen doctor (GP) for nerves, anxiety, tension or depression 1.35 1 0 0.0 0.00 1.0e+00 DENND1B
Hair/balding pattern: Pattern 4 0.97 1 0 0.0 0.00 1.0e+00 DEXI
Birth weight of first child 2.79 1 1 3.0 0.00 1.0e+00 SH2B3
Loud music exposure frequency 1.18 1 0 0.0 0.00 1.0e+00 RPL19
Blood clot in the leg (DVT) 1.14 1 0 0.0 0.00 1.0e+00 SH2B3
Medication for cholesterol, blood pressure or diabetes 2.14 2 1 3.0 0.00 1.0e+00 CARM1 SH2B3
Gout (self-reported) 3.66 2 0 0.0 0.00 1.0e+00 CCDC88B SH2B3
Hypothyroidism/myxoedema (self-reported) 7.19 5 2 6.1 0.53 3.6e-01 CCDC88B IRF5 SH2B3 SYNGR1 TMEM194B
Medication: Amlodipine 1.15 1 0 0.0 0.00 1.0e+00 SLC26A1
Medication: Ventolin 100micrograms inhaler 10.39 5 3 9.1 -0.62 1.3e-01 DEXI GSDMB ORMDL3 PNMT RPL19
Birth weight 1.15 1 1 3.0 0.00 1.0e+00 SH2B3
High blood pressure (siblings) 1.12 1 0 0.0 0.00 1.0e+00 SH2B3
Forced vital capacity (FVC), Best measure 0.92 2 0 0.0 0.00 1.0e+00 CARM1 RPL19
Body fat percentage 0.95 1 1 3.0 0.00 1.0e+00 SLC26A1
Leg fat percentage (right) 1.10 1 1 3.0 0.00 1.0e+00 SLC26A1
Arm fat-free mass (right) 1.27 3 1 3.0 0.00 1.0e+00 IFT80 SH2B3 SYNGR1
Exposure to tobacco smoke outside home 1.94 1 0 0.0 0.00 1.0e+00 SH2B3
Comparative body size at age 10 1.31 2 0 0.0 0.00 1.0e+00 IFT80 TRIM59
Wheeze or whistling in the chest in last year 6.66 5 4 12.1 -0.66 1.1e-01 DEXI GSDMB ORMDL3 PNMT RPL19
Number of children fathered 1.65 1 0 0.0 0.00 1.0e+00 DENND1B
Pulse wave peak to peak time 1.64 1 0 0.0 0.00 1.0e+00 CCDC88B
Qualifications: College or University degree 1.36 1 0 0.0 0.00 1.0e+00 CCDC88B
Emphysema/chronic bronchitis 2.54 2 0 0.0 0.00 1.0e+00 GSDMB ORMDL3
Medication: Blood pressure 2.54 1 1 3.0 0.00 1.0e+00 SH2B3
Medication: Allopurinol 2.90 2 0 0.0 0.00 1.0e+00 CCDC88B SH2B3
Medication: Seretide 50 evohaler 2.64 2 0 0.0 0.00 1.0e+00 DEXI ORMDL3
Mean time to correctly identify matches 1.96 1 1 3.0 0.00 1.0e+00 SH2B3
Whole body fat mass 0.89 2 0 0.0 0.00 1.0e+00 CCDC153 SLC26A1
Leg fat mass (right) 0.96 2 0 0.0 0.00 1.0e+00 CCDC153 SLC26A1
Arm predicted mass (right) 1.33 3 1 3.0 0.00 1.0e+00 IFT80 SH2B3 SYNGR1
Pulse rate, automated reading 1.54 3 0 0.0 0.00 1.0e+00 PNMT RPL19 TMEM194B
Alcohol intake frequency. 2.30 2 0 0.0 0.00 1.0e+00 GSDMB SLC9B1
Comparative height size at age 10 0.72 1 1 3.0 0.00 1.0e+00 SH2B3
Suffer from 'nerves' 1.88 1 0 0.0 0.00 1.0e+00 TRIM59
Overall health rating 1.36 1 0 0.0 0.00 1.0e+00 TRIM59
Chest pain or discomfort 2.19 2 0 0.0 0.00 1.0e+00 GSDMB ORMDL3
Medication: Aspirin 1.45 1 0 0.0 0.00 1.0e+00 SH2B3
Supplements: Vitamin C 3.36 2 0 0.0 -0.45 5.5e-01 GSDMB ORMDL3
Knee pain experienced in last month 1.90 1 0 0.0 0.00 1.0e+00 DEXI
Hypertension (Self-reported) 2.32 2 1 3.0 0.00 1.0e+00 SH2B3 TRIM59
Illnesses of father: Heart disease 1.70 1 0 0.0 0.00 1.0e+00 SH2B3
Smoking status: Previous 1.82 1 0 0.0 0.00 1.0e+00 SH2B3
Whole body fat-free mass 1.02 4 1 3.0 0.54 4.6e-01 IFT80 IL12RB2 SH2B3 SYNGR1
Leg fat-free mass (right) 0.83 3 0 0.0 0.00 1.0e+00 DENND1B IFT80 SH2B3
Arm fat percentage (left) 0.73 1 1 3.0 0.00 1.0e+00 SLC26A1
Average weekly red wine intake 2.35 1 0 0.0 0.00 1.0e+00 GSDMB
Loneliness, isolation 1.34 1 0 0.0 0.00 1.0e+00 SH2B3
Long-standing illness, disability or infirmity 2.45 1 0 0.0 0.00 1.0e+00 CCDC153
Diabetes diagnosed by doctor 2.03 1 0 0.0 0.00 1.0e+00 SH2B3
Mouth/teeth dental problems: Mouth ulcers 8.09 10 4 12.1 0.12 7.1e-01 DENND1B GSDMB IFT80 IL12RB2 IRF5 ORMDL3 PNMT SH2B3 SLC9B1 TRIM59
Medication for cholesterol 2.37 1 1 3.0 0.00 1.0e+00 SH2B3
Back pain experienced in last month 0.96 1 0 0.0 0.00 1.0e+00 SH2B3
Asthma (self-reported) 24.30 7 5 15.2 0.17 6.7e-01 CARM1 CCDC153 DEXI GSDMB ORMDL3 PNMT RPL19
Osteoporosis (self-reported) 1.54 1 0 0.0 0.00 1.0e+00 CCDC88B
Medication: Aspirin 1.43 1 0 0.0 0.00 1.0e+00 SH2B3
Illnesses of father: None of the above (group 1) 2.03 1 0 0.0 0.00 1.0e+00 SH2B3
Forced expiratory volume in 1-second (FEV1), predicted percentage 3.22 5 1 3.0 -0.37 4.7e-01 CCDC153 GSDMB ORMDL3 PNMT RPL19
Whole body water mass 1.04 3 1 3.0 0.00 1.0e+00 IFT80 SH2B3 SYNGR1
Leg predicted mass (right) 0.84 3 0 0.0 0.00 1.0e+00 DENND1B IFT80 SH2B3
Arm fat mass (left) 0.80 2 0 0.0 0.00 1.0e+00 DENND1B SLC26A1
Number of self-reported non-cancer illnesses 4.85 6 1 3.0 -0.56 1.9e-01 CCDC153 GSDMB IFT80 ORMDL3 SH2B3 TRIM59
Medication: Blood pressure 1.63 1 1 3.0 0.00 1.0e+00 SH2B3
High cholesterol (Self-reported) 2.66 1 1 3.0 0.00 1.0e+00 CARM1
Medication: Bendroflumethiazide 1.40 1 0 0.0 0.00 1.0e+00 SH2B3
Medication: Lisinopril 1.75 1 0 0.0 0.00 1.0e+00 SH2B3
Medication: Atorvastatin 1.72 1 0 0.0 0.00 1.0e+00 SLC26A1
Illnesses of father: High blood pressure 1.30 1 0 0.0 0.00 1.0e+00 SH2B3
Ever smoked 2.07 3 0 0.0 0.00 1.0e+00 CCDC88B RPL19 SH2B3
Basal metabolic rate 0.99 4 1 3.0 0.54 4.6e-01 IFT80 IL12RB2 SH2B3 SYNGR1
Leg fat percentage (left) 1.13 2 1 3.0 0.00 1.0e+00 CCDC153 SLC26A1
Arm fat-free mass (left) 1.29 5 1 3.0 0.41 5.0e-01 CCDC153 IFT80 IL12RB2 SH2B3 SYNGR1
Ever had prostate specific antigen (PSA) test 1.37 1 0 0.0 0.00 1.0e+00 SLC26A1
Diastolic blood pressure, automated reading 3.39 2 1 3.0 0.00 1.0e+00 INPP1 SH2B3
Myopia 2.65 3 0 0.0 0.02 9.8e-01 GSDMB ORMDL3 PNMT
Vascular/heart problems diagnosed by doctor 2.56 2 1 3.0 0.00 1.0e+00 SH2B3 TRIM59
Cholesterol lowering medication 2.99 2 1 3.0 0.00 1.0e+00 CARM1 SLC26A1
Pain experienced in last month 1.70 1 0 0.0 0.00 1.0e+00 SH2B3
Heart attack/myocardial infarction (self-reported) 1.97 1 0 0.0 0.00 1.0e+00 SH2B3
Deep venous thrombosis (DVT) (self-reported) 1.19 1 0 0.0 0.00 1.0e+00 SH2B3
Impedance of whole body 0.99 2 0 0.0 0.00 1.0e+00 IFT80 SLC9B1
Leg fat mass (left) 1.01 2 0 0.0 0.00 1.0e+00 CCDC153 SLC26A1
Arm predicted mass (left) 1.27 5 1 3.0 0.38 5.3e-01 CCDC153 IFT80 IL12RB2 SH2B3 SYNGR1

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 4 0.1164 1.46
GTEx Adipose Visceral Omentum 1 0.0498 1.48
GTEx Adrenal Gland 2 0.1394 1.58
GTEx Artery Aorta 2 0.0682 1.47
GTEx Artery Coronary 2 0.1714 1.54
GTEx Artery Tibial 2 0.0541 1.39
GTEx Brain Caudate basal ganglia 1 0.1103 1.50
GTEx Brain Cerebellar Hemisphere 1 0.0680 1.41
GTEx Brain Cerebellum 1 0.0509 1.41
GTEx Brain Cortex 2 0.1955 1.63
GTEx Brain Frontal Cortex BA9 1 0.1099 1.57
GTEx Brain Hippocampus 0 0.0000 1.54
GTEx Brain Hypothalamus 0 0.0000 1.54
GTEx Brain Nucleus accumbens basal ganglia 1 0.1168 1.50
GTEx Brain Putamen basal ganglia 1 0.1623 1.65
GTEx Breast Mammary Tissue 1 0.0513 1.44
GTEx Breast Mammary Tissue (Male) 2 0.1712 1.56
GTEx Breast Mammary Tissue (Female) 1 0.0623 1.40
GTEx Cells EBV-transformed lymphocytes 3 0.2143 1.53
GTEx Cells Transformed fibroblasts 6 0.1451 1.48
GTEx Colon Sigmoid 2 0.1385 1.50
GTEx Colon Transverse 2 0.0984 1.47
GTEx Esophagus Gastroesophageal Junction 0 0.0000 1.48
GTEx Esophagus Mucosa 1 0.0306 1.49
GTEx Esophagus Muscularis 1 0.0315 1.50
GTEx Heart Atrial Appendage 2 0.1281 1.52
GTEx Heart Left Ventricle 1 0.0665 1.46
GTEx Liver 0 0.0000 1.55
GTEx Lung 5 0.1769 1.51
GTEx Muscle Skeletal 2 0.0704 1.44
GTEx Nerve Tibial 1 0.0235 1.46
GTEx Ovary 1 0.1116 1.51
GTEx Pancreas 4 0.2477 1.54
GTEx Pituitary 3 0.2715 1.54
GTEx Prostate 0 0.0000 1.42
GTEx Skin Not Sun Exposed Suprapubic 0 0.0000 1.46
GTEx Skin Sun Exposed Lower leg 5 0.1397 1.49
GTEx Small Intestine Terminal Ileum 0 0.0000 1.61
GTEx Spleen 3 0.2157 1.51
GTEx Stomach 1 0.0695 1.46
GTEx Testis 2 0.0644 1.50
GTEx Thyroid 2 0.0509 1.42
GTEx Uterus 0 0.0000 1.59
GTEx Vagina 0 0.0000 1.50
GTEx Whole Blood 6 0.3064 1.55
METSIM Adipose 3 0.0659 1.40
NTR Blood 6 0.2509 1.54
ROSMAP Brain Pre-frontal Cortex 3 0.0693 1.34
YFS Blood 6 0.1302 1.47
CommonMind Brain Pre-frontal Cortex 8 0.1500 1.40
TCGA Breast Tumor 1 0.1314 1.62
TCGA Breast Normal 4 0.0962 1.33
TCGA Ovarian Tumor 1 0.0345 1.31
TCGA Prostate Tumor 3 0.0879 1.41